SE8200591L - PROCEDURE FOR PREPARING A COMPOSITION CONTAINING A LYOPHILIZED PENICILLIN DERIVATIVE - Google Patents

PROCEDURE FOR PREPARING A COMPOSITION CONTAINING A LYOPHILIZED PENICILLIN DERIVATIVE

Info

Publication number
SE8200591L
SE8200591L SE8200591A SE8200591A SE8200591L SE 8200591 L SE8200591 L SE 8200591L SE 8200591 A SE8200591 A SE 8200591A SE 8200591 A SE8200591 A SE 8200591A SE 8200591 L SE8200591 L SE 8200591L
Authority
SE
Sweden
Prior art keywords
lyophilized
penicillin derivative
preparing
procedure
composition containing
Prior art date
Application number
SE8200591A
Other languages
Unknown language ( )
Swedish (sv)
Other versions
SE453153B (en
Inventor
B E Haeger
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22935482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8200591(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of SE8200591L publication Critical patent/SE8200591L/en
Publication of SE453153B publication Critical patent/SE453153B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Preparation of a pharmaceutical parenteral dosage unit of a lyophilized penicillin derivative in which the penicillin derivative is dissolved in water to a concentration of 100-135 mg/ml, as compared to the standard concentration of 200 mg/ml. The solution is then filled into a container and lyophilized by known techniques. The product is a light, fluffy lyophilized product which upon reconstitution will go into solution rapidly and completely even at the high concentration of 400 mg/ml.
SE8200591A 1981-03-26 1982-02-02 PROCEDURE FOR PREPARING A PHARMACEUTICAL PARENTERAL DOSAGE UNIT OF LYOPHILIZED SODIUM PIPERACILLIN SE453153B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24758681A 1981-03-26 1981-03-26

Publications (2)

Publication Number Publication Date
SE8200591L true SE8200591L (en) 1982-09-27
SE453153B SE453153B (en) 1988-01-18

Family

ID=22935482

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8200591A SE453153B (en) 1981-03-26 1982-02-02 PROCEDURE FOR PREPARING A PHARMACEUTICAL PARENTERAL DOSAGE UNIT OF LYOPHILIZED SODIUM PIPERACILLIN

Country Status (23)

Country Link
JP (1) JPS57159708A (en)
AT (1) AT395533B (en)
AU (1) AU549784B2 (en)
BE (1) BE892541A (en)
CA (1) CA1209477A (en)
CH (1) CH652306A5 (en)
DE (2) DE19375106I2 (en)
DK (1) DK157976C (en)
ES (1) ES8302455A1 (en)
FR (1) FR2502624B1 (en)
GB (1) GB2095551B (en)
GR (1) GR78386B (en)
HK (1) HK39189A (en)
HU (1) HU186489B (en)
IE (1) IE52936B1 (en)
IL (1) IL64924A (en)
IT (1) IT1147916B (en)
LU (1) LU84031A1 (en)
NL (1) NL192664C (en)
NZ (1) NZ199632A (en)
PL (1) PL130564B1 (en)
SE (1) SE453153B (en)
ZA (1) ZA82605B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207661B1 (en) 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
GEP20115205B (en) 2003-10-23 2011-04-26 Otsuka Pharma Co Ltd Controlled release sterile injectable aripiprazole formulation and method
ITMI20051630A1 (en) * 2005-09-02 2007-03-03 Acs Dobfar Spa INJECTABLE STERILE PHARMACEUTICAL FORMULATION CONTAINING AT LEAST TWO ACTIVE PRINCIPLES
US9457026B2 (en) 2007-07-31 2016-10-04 Otsuka Pharmaceutical Co., Ltd. Methods for producing aripiprazole suspension and freeze-dried formulation
CN114200057A (en) * 2021-12-14 2022-03-18 坛墨质检科技股份有限公司 Preparation method of antibiotic medicine solid mixed standard substance capable of replacing standard solution

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2608507A (en) * 1949-08-20 1952-08-26 Sharp & Dohme Inc Dialkyl sulfamyl benzoic acids
CH546783A (en) * 1971-03-11 1974-03-15 Hoffmann La Roche PROCESS FOR THE PRODUCTION OF PENICILLOIC ACID DERIVATIVES.
JPS5817728B2 (en) * 1973-11-20 1983-04-09 山之内製薬株式会社 Ampicillin Sodium
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS52143221A (en) * 1976-05-22 1977-11-29 Yamanouchi Pharmaceut Co Ltd Novel preparations for rectal administration
DE2623835C2 (en) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Process for the manufacture of sodium amphicillin
JPS542337A (en) * 1977-06-08 1979-01-09 Toyama Chem Co Ltd Bactericidal composition for medical use
FR2403078A1 (en) * 1977-09-19 1979-04-13 Lafon Labor NEW PROCESS FOR THE PREPARATION OF PHARMACEUTICAL, COSMETIC OR DIAGNOSIS FORMS
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
DE2925009A1 (en) * 1979-06-21 1981-01-08 Basf Ag PREPARATION FOR SUBSTANCES, METHOD FOR THE PRODUCTION AND USE THEREOF

Also Published As

Publication number Publication date
GR78386B (en) 1984-09-26
DE3208505C2 (en) 1991-11-28
AT395533B (en) 1993-01-25
DE19375106I2 (en) 2006-02-16
NZ199632A (en) 1985-07-12
HU186489B (en) 1985-08-28
IT1147916B (en) 1986-11-26
NL8201251A (en) 1982-10-18
LU84031A1 (en) 1982-07-08
ES509234A0 (en) 1982-12-16
JPH0219804B2 (en) 1990-05-07
DK157976C (en) 1990-08-27
CH652306A5 (en) 1985-11-15
GB2095551B (en) 1984-10-03
IT8248034A0 (en) 1982-03-19
PL235509A1 (en) 1982-12-20
NL192664C (en) 1997-12-02
IL64924A (en) 1985-07-31
HK39189A (en) 1989-05-19
IL64924A0 (en) 1982-04-30
AU549784B2 (en) 1986-02-13
BE892541A (en) 1982-09-20
IE52936B1 (en) 1988-04-13
CA1209477A (en) 1986-08-12
NL192664B (en) 1997-08-01
AU7986582A (en) 1982-09-30
ATA92982A (en) 1992-06-15
ES8302455A1 (en) 1982-12-16
JPS57159708A (en) 1982-10-01
DK157976B (en) 1990-03-12
FR2502624B1 (en) 1985-10-25
IE820703L (en) 1982-09-26
GB2095551A (en) 1982-10-06
PL130564B1 (en) 1984-08-31
DK48382A (en) 1982-09-27
DE3208505A1 (en) 1982-10-21
ZA82605B (en) 1982-12-29
FR2502624A1 (en) 1982-10-01
SE453153B (en) 1988-01-18

Similar Documents

Publication Publication Date Title
SE8402549L (en) SUBSTITUTED MORANOLINE DERIVATIVES
AU6805781A (en) Oral absorption of polar bioactive agents
HU906341D0 (en) Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
GB1518843A (en) Process for the preparation of hollow particulates
DE2961284D1 (en) Tetrahydropyridinyl indole derivatives and their salts, process for their preparation, their use as medicines and pharmaceutical compositions containing them
SE7707462L (en) PROCEDURE FOR PREPARING PENICILLANIC ACID DERIVATIVES
SE8200591L (en) PROCEDURE FOR PREPARING A COMPOSITION CONTAINING A LYOPHILIZED PENICILLIN DERIVATIVE
PT75217A (en) Authoritative medicinal preparations of xanthine derivatives and method for their preparation
DE3688087T2 (en) CEPHEMIC COMPOUNDS, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME.
GB2021946A (en) Pharmaceutical Formulations Containing Cis-platinum (II) Diamminedichloride
KR920702225A (en) Pharmaceutical composition
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
IL82925A0 (en) Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them
ATE1066T1 (en) AMINOPROPANOL DERIVATIVES OF 6-HYDROXY-2,3,4,5-TETRAHY DRO-1H-1-BENZAZEPINE-2-ONE, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
FR2703048B1 (en) NOVEL N-BENZYLPIPERAZINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
EP0313997A3 (en) Medicine, therein contained phosphor containing 2-isoxazmedicine, therein contained phosphor containing 2-isoxazolidines and isoxazoles, as well as process for preparinolidines and isoxazoles, as well as process for preparing those heterocyclic compounds g those heterocyclic compounds
SE8106498L (en) QUATERATE SALTS OF N, N3-DI (BETA-BROMOPROPIONYL) -N1, N2-DISPIROTRIPIPERAZINIUM, PROCEDURE FOR PREPARING THESE AND MEDICINAL PREPARED CONTENTS
FR2554819B1 (en) NOVEL THIENO (2,3-B) PYRROLE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
KR830004848A (en) Method for preparing injectable dosage unit of dog dried compound of penicillin derivative
SE8600830L (en) AMPULOUS DISPOSAL OF 7- (DIMETHYLAMINOMETHYL) AMINO-9A-METOXIMITOSAN
SU1090404A1 (en) Method of preparing sibasone solution for injections
FR2496658B1 (en) NICOTINIC ACID DERIVATIVES, THEIR PREPARATION AND THE MEDICINE CONTAINING THESE SUBSTANCES
BE787809A (en) PHENYLACETIC ACID DERIVATIVES, THEIR PROCESS FOR PREPARATION AND THERAPEUTIC COMPOSITION CONTAINING THEM
EP0229963A3 (en) 4-thienyl-dihydropyridines, process for their preparation and their use as pharmaceutical preparations
JPS57136586A (en) Cephalosporin derivative and its preparation

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8200591-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8200591-9

Format of ref document f/p: F